The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025? [PDF]
Sempere A +17 more
europepmc +1 more source
Co-cultivation and Medium Optimization: A Strategy for Discovering Fungal-derived Protease Inhibitors. [PDF]
Mazucato VS +7 more
europepmc +1 more source
Gene expression and evolution of Bowman-Birk protease inhibitors in wild and domesticated <i>Vigna</i> (Fabaceae) species. [PDF]
Toini E +10 more
europepmc +1 more source
Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. [PDF]
Coria LM +5 more
europepmc +1 more source
Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants. [PDF]
Cai Z +13 more
europepmc +1 more source
Design and synthesis of 1,3,4-oxadiazole-tethered <i>N</i>-substituted isatin hybrids as SARS-CoV-2 main protease inhibitors: biological evaluation, kinetic investigation, and <i>in silico</i> studies. [PDF]
Al-Warhi T +10 more
europepmc +1 more source
SARS-CoV‑2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene Moieties. [PDF]
Shinohara K +5 more
europepmc +1 more source
HIV protease inhibitors restore amphotericin B activity against Candida. [PDF]
Elgammal Y, Salama EA, Seleem MN.
europepmc +1 more source
Fluorinated HIV-1 protease inhibitors containing chiral hydroxyethylbenzene and indanol as P2' ligands with potent activity against drug-resistant variants. [PDF]
Kaur J +10 more
europepmc +1 more source
Bacteria associated with the cereal leaf beetle act as the insect's allies in adapting to protease inhibitors, but impair its development in laboratory condition. [PDF]
Wielkopolan B +2 more
europepmc +1 more source

